Pangali P/E Stoke Therapeutics Inc (STOK)
Stoke Therapeutics is developing genetic therapies through partnerships with pharma behemoths, which accelerates testing. The company's P/E dynamics visualize the market valuation of these successes, where -7.50 shows the current value of the metric. Cost optimization through the outsourcing of production and IT infrastructure supports R&D efficiency, while positive data on Dravet syndrome therapy serves as the primary driver of value growth.
Rincian metrik komprehensif lan analitis Stoke (STOK)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- informasi babagan utang lan solvabilitas:
Utang Agregat marang Modal Stoke Therapeutics|STOK - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Stoke Corp|STOK - Gunggung utang perusahaan|Utang-utang marang nilai buku Stoke Therapeutics, Inc.|STOK - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Stoke Therapeutics|Rasio cepet stoketherapeutics.com
- data bathi bisnis lan rasio investasi:
STOK - Bathi resik perusahaan|Bathi forward Stoke Therapeutics|STOK - Pangali P/E|Rasio prakiraan rega marang bathi Stoke Therapeutics Inc|STOK - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Stoke Therapeutics, Inc.|STOK - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Stoke Therapeutics|STOK - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan stoketherapeutics.com|STOK - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Stoke Therapeutics
Ringkesan analisis perusahaan:STOK (stoketherapeutics.com)
The P/E ratio determines the market value of a business relative to its annual net income, allowing an investor to assess the investment payback period and avoid value traps. For Stoke Therapeutics (STOK) and its lifelong RNA-based therapies, the current P/E valuation reflects market expectations of stable demand and long-term monetization of rare diseases.
Analisis perusahaan pesaing
Kapitalisasi marang bathi Tempus AI Inc TEM|Rasio rega marang bathi Qiagen (QGEN)|Pangali P/E Ionis Pharmaceuticals, Inc. (IONS)|Pangali P/E RGEN (Repligen Corp.)|Avidity Corp (RNA) - Kapitalisasi marang bathi|CRSP: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik WGS (genedx.com)|RARE (Ultragenyx) - Koefisien rega marang bathi|BEAM: Rasio rega pasar marang bathi resik|SRPT (Sarepta Therapeutics Inc) - Pangali P/E|TWST: Nilai perusahaan marang bathi resik|Pangali P/E TXG|NTLA - Kapitalisasi marang bathi|Rasio rega marang bathi BioLife Solutions BLFS|Nilai perusahaan marang bathi resik WVE|Maze Tx - Pangali P/E|SION - Pangali P/E|Prime Medicine, Inc. (PRME) - Rasio rega marang bathi|Kapitalisasi marang bathi resik TSHA (tayshagtx.com)|QURE (uniQure) - Pangali P/E|Kapitalisasi marang bathi MeiraGTx Holdings MGTX|Koefisien rega marang bathi RGNX (Regenxbio)|Pangali P/E Solid Corp (SLDB)|Ocugen, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik PACB (pacb.com)|Benitec Biopharma - Pangali P/E|Periode bali modal bisnis Design Therapeutics Inc DSGN|RCKT: Pangali P/E|Koefisien rega marang bathi 4D Molecular Corp|Rasio rega marang bathi Lexeo Therapeutics Inc.|Korro Bio, Inc (KRRO) - Periode bali modal bisnis|Rasio rega marang bathi Editas Medicine (EDIT)|Periode bali modal bisnis Silence Therapeutics PLC|ProQR Therapeutics - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik CDXS (Codexis Inc)|SGMO - Rasio rega marang bathi|Kapitalisasi marang bathi Nautilus Biotechnology|Metagenomi (MGX) - Rasio rega marang bathi|precisionbiosciences.com (DTIL) - Pangali P/E|GBIO (Generation Bio Co) - Pangali P/E|Pangali rega marang bathi BOLD (Boundless Bio Inc)|Rasio rega marang bathi Exicure, Inc. (XCUR)|imunon.com - Pangali rega marang bathi|Pangali P/E PHIO (Phio Pharmaceuticals Corp.)|Pangali P/E Mustang Bio Inc MBIO|RNAZ - Rasio rega marang bathi|Periode bali modal bisnis Bionano Genomics, Inc. BNGO|APDN (Applied DNA Sciences) - Koefisien rega marang bathi|BLUE: Rasio rega pasar marang bathi resik|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd|Kapitalisasi marang bathi Omega Therapeutics Inc OMGA|Rasio rega marang bathi Singular Genomics Systems Inc (OMIC)|Pangali P/E Regulus (RGLS)|Pangali P/E SYRS (Syros Pharmaceuticals)|telesisbio.com (TBIO) - Kapitalisasi marang bathi|TCON: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik UBX (Unity Biotechnology Inc.)
